Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 7/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | HPGDS | O60760 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18540383 | 0.96 | HSD17B1 (0.39) | CYP11B1HSD17B1HSD17B2LDHAIDO1 | |
| SCHEMBL18540374 | 0.83 | KDM1A (0.35) | CYP11B1HSD17B1HSD17B2IDO1CYP11B2 | |
| SCHEMBL18540381 | 0.83 | DHFR (0.36) | CYP11B1HSD17B1HSD17B2IDO1TDO2 | |
| SCHEMBL17952949 | 0.83 | HSD17B1 (0.53) | CYP11B1HSD17B1HSD17B2LDHAIDO1 | |
| SCHEMBL16405288 | 0.83 | HSD17B1 (0.45) | CYP11B1HSD17B1HSD17B2LDHAIDO1 | |
| SCHEMBL17780846 | 0.81 | LDHA (0.48) | CYP11B1LDHAIDO1TDO2CYP11B2 | |
| SCHEMBL29505097 | 0.81 | LDHA (0.48) | CYP11B1LDHAIDO1TDO2CYP11B2 | |
| SCHEMBL18540403 | 0.80 | CYP11B1 (0.31) | CYP11B1 | |
| SCHEMBL18540419 | 0.79 | — | — | |
| SCHEMBL31754774 | 0.79 | HSD17B1 (0.43) | HSD17B1HSD17B2LDHAIDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220093880-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2022-03-24 | — | — | US | disclosed |
| US-11211571-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-12-28 | — | — | US | disclosed |
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2017-02-23 | — | — | US | disclosed |
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220093880-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, LEF1, POU2F1 | CYP11B1 766/4885HSD17B1 1490/4885HSD17B2 1944/4885 |
| US-11211571-B2 | Organometallic compound and organic light-emitting device including the same | CRY1, LEF1, POU2F1 | CYP11B1 766/4885HSD17B1 1490/4885HSD17B2 1944/4885 |
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, LEF1, POU2F1 | CYP11B1 766/4885HSD17B1 1490/4885HSD17B2 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.